Delivering on the promise of personalized breast cancer therapy
A test predicts with a high degree of confidence which breast cancer patients would benefit the most from a therapy de-escalation approach.
Read MoreA test predicts with a high degree of confidence which breast cancer patients would benefit the most from a therapy de-escalation approach.
Read MoreThe findings in animal models warrant continuing investigations to develop a novel, more effective and longer-lasting cancer therapy.
Read MoreThese studies improve our understanding of both human biology and practical clinical issues.
Read MoreThe findings open new possibilities for novel therapies to provide much needed relief to patients with this condition.
Read MoreThe researchers also developed a strategy that reduced tumor growth and improved survival in tumor-bearing mice.
Read MoreThe researchers identified ways to accelerate the restoration of the normal immune response and the efficacy of immunotherapies in animal models.
Read MoreHow does an inquisitive undergraduate public health major find herself conducting bioethics research at one of the leading research institutions in the country? With a
Read MoreResearchers discussed the latest cutting-edge, translational and clinical research focusing on pediatric hematology and oncology.
Read MoreThe findings support evaluating targeting kinase enzymes in a clinical trial to treat this type of breast cancer.
Read MoreGlyNAC – a combination of precursors of the natural antioxidant glutathione – improved or reversed age-associated cognitive decline in old mice and improved multiple associated defects in the aging brain.
Read More